0000950170-23-063176.txt : 20231113
0000950170-23-063176.hdr.sgml : 20231113
20231113174603
ACCESSION NUMBER: 0000950170-23-063176
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231110
FILED AS OF DATE: 20231113
DATE AS OF CHANGE: 20231113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WAUD REEVE B
CENTRAL INDEX KEY: 0001421620
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35331
FILM NUMBER: 231400383
MAIL ADDRESS:
STREET 1: 300 N LASALLE ST
STREET 2: SUITE 4900
CITY: CHICAGO
STATE: IL
ZIP: 60654
FORMER NAME:
FORMER CONFORMED NAME: Waud Reeve
DATE OF NAME CHANGE: 20071218
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acadia Healthcare Company, Inc.
CENTRAL INDEX KEY: 0001520697
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6100 TOWER CIRCLE
STREET 2: SUITE 1000
CITY: FRANKLIN
STATE: TN
ZIP: 37067
BUSINESS PHONE: 615-861-6000
MAIL ADDRESS:
STREET 1: 6100 TOWER CIRCLE
STREET 2: SUITE 1000
CITY: FRANKLIN
STATE: TN
ZIP: 37067
4
1
ownership.xml
4
X0508
4
2023-11-10
0001520697
Acadia Healthcare Company, Inc.
ACHC
0001421620
WAUD REEVE B
C/O WAUD CAPITAL PARTNERS, L.L.C.
300 N. LASALLE STREET, SUITE 4900
CHICAGO
IL
60654
true
false
false
false
false
Common Stock, par value $0.01 per share
2023-11-10
4
A
false
68028
73.02
A
653015
I
See Footnotes
Common Stock, par value $0.01 per share
36218
D
Represents shares purchased by the Halcyon Exempt Family Trust (the "Halcyon Trust").
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $71.90 to $73.50, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The shares are owned of record as follows: (i) 225,519 shares by the Halcyon Trust, (ii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iii) 155,930 shares by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust"), (v) 43,643 shares by the Cornelius Byron Waud 2002 Trust (the "2002 CBW Family Trust"), and (vi) 34,500 shares by the Corinna Reeve Waud 2002 Trust ("2002 CRW Family Trust").
Mr. Waud may be deemed to beneficially own the shares of common stock described above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being the sole manager of WCP LLC, (C) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries, and (D) his being appointed, in June 2023, as the co-trustee of the 2002 CBW Family Trust and the 2002 CRW Family Trust of which Mr. Waud's parents are beneficiaries.
Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.
/s/ Reeve B. Waud
2023-11-13